Background Among patients with suspected acute coronary syndromes, cardiac troponin T
levels have prognostic value. However, there is concern that renal dysfunction may impair …

SciELO - Brasil - Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e
Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021 Diretrizes da …

Background Diabetes mellitus is a major risk factor for adverse outcomes after acute
coronary syndromes (ACS). Because this disease may be associated with increased platelet …

Aims The extent to which hospital and geographic characteristics influence the time course
of uptake of evidence from key clinical trials and practice guidelines is unknown. The gap …

Objectives: We sought to evaluate C-reactive protein (CRP) and troponin T (TnT) as
predictors of risk of the individual end points of mortality and myocardial infarction (MI) in a …

Chronic kidney disease (CKD) is associated with a high risk of death from coronary artery
disease and may modify the response to standard cardiovascular therapies. Treatment of …

Background—Glycoprotein (GP) IIb/IIIa inhibitors are beneficial in patients with non–ST-
segment elevation acute coronary syndromes (NSTE ACS); their safe use in women …

Antiplatelet therapy has been the focus of extensive clinical investigations over the last two
decades. A variety of agents and regimens have been advanced for the prevention and …

Each year, a large number of patients are seen in the Emergency Department with
presentations necessitating investigation for possible acute myocardial infarction. Patients …

More than 1.2 million percutaneous coronary interventions are performed annually in the
United States, with only an estimated 33% performed in women, despite the established …